(14) Uncontrolled thyroid disease
While the FDA labels acknowledge reports of acute gallbladder disease, they do not establish definitive causation, and the absolute risk remains relatively low for most patients
Never adjust or discontinue either medication without medical guidance
Please know that our commitment to the obesity community is a long-term one and we are investing significantly to build capacity to meet this increasing demand. Demand for Wegovy is skyrocketing, with the number of prescriptions filled in the first four months of 2023 jumping 568% compared to the same period last year, according to SingleCare, a prescription savings service
371 In osteoblasts, the administration of GLP-1 and GIP incretins suppressed the excessive expression of the pro-degradative enzymes MMP-3 and MMP-13 induced by IL-1 stimulation
Clinical Update 12/05/2023 Fatty Liver & C15:0 Did supplementing with C15:0 help people with fatty liver disease